Unlikely to cause harm — often a labeling or packaging issue.
Failed Dissolution Specifications
| Brand name | BUPROPION HYDROCHLORIDE |
| Generic name | BUPROPION HYDROCHLORIDE |
| Active ingredient(s) | BUPROPION HYDROCHLORIDE |
| Distributed by / for | Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 |
| NDC | 47335-737-86 |
| Full product label | buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, Twice-A-Day, in 60 count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by Sun Pharmaceuticals Ind. Ltd. Halol- Baroda Highway, Halol-389 350, Gujarat, India. UPC 347335737868 NDC 47335-737-86 |
| Recalling firm | Sun Pharmaceutical Industries, Inc. |
| Distribution | Nationwide |
| Quantity | 31,762 bottles |
| Recall initiated | 2016-09-13 |
| Report date | 2016-10-12 |
| Recall completed | 2018-07-02 |
| Recall number | D-0007-2017 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Cranbury NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗